• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Inaugural DNDi training for health & science journalists in Kampala

Home > News

Inaugural DNDi training for health & science journalists in Kampala

16 Oct 2018
Medical journalist Dr Mercy Korir
Medical journalist Dr Mercy Korir

In early October, 18 journalists from 11 African countries converged in Kampala, Uganda for DNDi’s first-ever training on health and science journalism. The three-day training was conducted on the sidelines of DNDi’s 11th Partners’ Meeting on 4 October 2018.

The objective of the health and science journalism workshop was to help reporters and editors better understand neglected diseases prevalent in the region and grasp the science behind efforts to develop new drugs for these diseases.

Mr Otula Owuor, a veteran Kenyan science journalist and trainer with the World Federation of Science Journalists, facilitated the training, which alternated presentations with interactive sessions. The journalists learned about neglected diseases directly from DNDi experts, including onchocerciasis (river blindness), mycetoma, human African trypanosomiasis (sleeping sickness), and leishmaniasis, and neglected patient populations such as children living with HIV. Dr Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases at DNDi, helped to “demystify” the clinical trials process with an in-depth talk on the ins and outs of drug development.

The journalists visited the Joint Clinical Research Centre in Lubowa, a clinical trial site for DNDi’s LIVING study, underway in Kenya and Uganda to demonstrate the effectiveness, safety, and acceptability of child-adapted HIV therapy, the so-called “2-in-1” pellets containing lopinavir and ritonavir (LPV/r), which are designed for infants and young children. The visit helped to improve the journalists’ understanding of what takes place during a clinical trial and gave them the opportunity to ask questions of Ugandan clinical trial experts.

Equipped with new skills and understanding, the journalists are already developing stories about neglected diseases and patients in their countries, and about related research and development activities.

A selection of articles published by participants of the workshop:

  • Al Jazeera Africa [27 March 2019] طبيبة كينية تعالج الناس بالصحافة “A Kenyan doctor treats people in the press”
  • New Business Ethiopia [9 February 2019] “Ethiopia makes progress against neglected tropical diseases”
  • The East African [1 November 2018] “New treatments offer hope for tropical diseases in Africa”
  • Habari RDC [24 October 2018] “Un nouveau medicament pour soigner la maladie du sommeil”
  • Politico DRC [14 October 2018] “Maladies tropicales négligées:les experts signalent des progrès dans l’éradication de la Trypanosomiase en RDC”
  • The Citizen [11 October 2018] “Children’s HIV drug formula developed”
  • Ghana Web [11 October 2018] “More resources needed to fight against neglected tropical diseases – Health experts”
  • Ghana Web [11 October 2018] “Pediatric HIV victims get attention”
  • Daily Monitor [10 October 2018] “HIV-positive children to take soluble ARVs”
  • The Star Tribune [8 October 2018] “Health organization celebrates 15 years fighting neglected diseases globally”
  • New Business Ethiopia [3 October 2018] “New clinical trials for neglected diseases in eastern Africa in progress”
  • Daily Nation [3 October 2018] “Children to get HIV drugs in powder form”
  • The Standard [3 October 2018] “Ray of hope for children with HIV and Aids”
Strengthening Capacities Paediatric HIV Africa Uganda

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License